VLS-1488-2201

A phase I/II study of VLS-1488 (an oral KIF18A inhibitor) in subjects with advanced cancer
Status:

Open

Trial Type:
Early Phase Trials for Multiple Cancer Types

Contact:

Cara Mathews, MD
cmathews@wihri.org

©2024 Brown Cancer Clinical Trials